Found: 5
Select item for more details and to access through your institution.
False negatives in GBA1 sequencing due to polymerase dependent allelic imbalance.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-020-80564-y
- By:
- Publication type:
- Article
A randomized single and multiple ascending dose study in healthy volunteers of LTI‐291, a centrally penetrant glucocerebrosidase activator.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 9, p. 3561, doi. 10.1111/bcp.14772
- By:
- Publication type:
- Article
A Phase 1B Trial in GBA1‐Associated Parkinson's Disease of BIA‐28‐6156, a Glucocerebrosidase Activator.
- Published in:
- Movement Disorders, 2023, v. 38, n. 7, p. 1197, doi. 10.1002/mds.29346
- By:
- Publication type:
- Article
A Biomarker Study in Patients with GBA1‐Parkinson's Disease and Healthy Controls.
- Published in:
- Movement Disorders, 2023, v. 38, n. 5, p. 783, doi. 10.1002/mds.29360
- By:
- Publication type:
- Article
A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands.
- Published in:
- 2020
- By:
- Publication type:
- journal article